EXPORT CITATION

Chapter-169 Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis

BOOK TITLE: Year Book of Medicine 2018

Author
1. Handa Rohini
2. Sharma Aman
3. Misra Durga Prasanna
ISBN
9789352705115
DOI
10.5005/jp/books/18440_170
Edition
1/e
Publishing Year
2018
Pages
1
Author Affiliations
1. Apollo Indraprastha Hospital, New Delhi, India, All India Institute of Medical Sciences, New Delhi, Apollo Indraprastha Hospitals, New Delhi, India, Indraprastha Apollo Hospitals, New Delhi, India
2. Postgraduate Institute of Medical Education and Research, Chandigarh, India, Apollo Hospital, Bilaspur, Chhattisgarh, India, PGIMER, Chandigarh, India, New Cross Hospital, Wolverhampton, United Kingdom, Post Graduate Institute of Medical Education and Research, Chandigarh, India, Postgraduate Institute of Medical, Education and Research (PGIMER), Chandigarh, India
3. Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India, SGPGI, Lucknow, Uttar Pradesh, India
Chapter keywords
Tofacitinib, adalimumab, psoriatic arthritis, Janus kinase inhibitor, disease-modifying antirheumatic drug, placebo-controlled trial, phase 3 trial, health assessment questionnaire–disability index, HAQ-DI

Abstract

Related Books

© 2019 Jaypee Brothers Medical Publishers (P) LTD.   |   All Rights Reserved